Absence of integrin α3β1 promotes the progression of HER2-driven breast cancer in vivo

BACKGROUND: HER2-driven breast cancer is correlated with poor prognosis, especially during its later stages. Numerous studies have shown the importance of the integrin α3β1 during the initiation and progression of breast cancer; however, its role in this disease is complex and often opposite during...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramovs, Veronika, Secades, Pablo, Song, Ji-Ying, Thijssen, Bram, Kreft, Maaike, Sonnenberg, Arnoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525362/
https://www.ncbi.nlm.nih.gov/pubmed/31101121
http://dx.doi.org/10.1186/s13058-019-1146-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525362/
https://www.ncbi.nlm.nih.gov/pubmed/31101121
http://dx.doi.org/10.1186/s13058-019-1146-8

Ejemplares similares